

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.37150650 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 6.37150650 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.93884220 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.93884220 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 5.70656692 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.34703794 |
| 7 | protein carboxylation (GO:0018214) | 5.24777360 |
| 8 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.24777360 |
| 9 | indole-containing compound catabolic process (GO:0042436) | 5.10640320 |
| 10 | indolalkylamine catabolic process (GO:0046218) | 5.10640320 |
| 11 | tryptophan catabolic process (GO:0006569) | 5.10640320 |
| 12 | complement activation, alternative pathway (GO:0006957) | 5.07722635 |
| 13 | urea metabolic process (GO:0019627) | 5.00974612 |
| 14 | urea cycle (GO:0000050) | 5.00974612 |
| 15 | tryptophan metabolic process (GO:0006568) | 4.89261981 |
| 16 | bile acid biosynthetic process (GO:0006699) | 4.87941254 |
| 17 | kynurenine metabolic process (GO:0070189) | 4.86480070 |
| 18 | negative regulation of protein activation cascade (GO:2000258) | 4.66315970 |
| 19 | regulation of protein activation cascade (GO:2000257) | 4.62842173 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 4.59218678 |
| 21 | nitrogen cycle metabolic process (GO:0071941) | 4.56833030 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 4.50302398 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 4.38724988 |
| 24 | regulation of complement activation (GO:0030449) | 4.37977105 |
| 25 | regulation of fibrinolysis (GO:0051917) | 4.33515384 |
| 26 | glyoxylate metabolic process (GO:0046487) | 4.29825063 |
| 27 | cysteine metabolic process (GO:0006534) | 4.24803297 |
| 28 | plasma lipoprotein particle clearance (GO:0034381) | 4.20174685 |
| 29 | bile acid metabolic process (GO:0008206) | 4.19261807 |
| 30 | negative regulation of complement activation (GO:0045916) | 4.19024422 |
| 31 | epoxygenase P450 pathway (GO:0019373) | 4.14663815 |
| 32 | sulfur amino acid catabolic process (GO:0000098) | 4.14623000 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.14007720 |
| 34 | homocysteine metabolic process (GO:0050667) | 4.13536161 |
| 35 | plasma lipoprotein particle remodeling (GO:0034369) | 4.12811832 |
| 36 | protein-lipid complex remodeling (GO:0034368) | 4.12811832 |
| 37 | macromolecular complex remodeling (GO:0034367) | 4.12811832 |
| 38 | phospholipid efflux (GO:0033700) | 4.06869951 |
| 39 | tyrosine metabolic process (GO:0006570) | 4.06850905 |
| 40 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.04372181 |
| 41 | aromatic amino acid family metabolic process (GO:0009072) | 4.04209012 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.01683292 |
| 43 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.90196246 |
| 44 | aldehyde catabolic process (GO:0046185) | 3.88390142 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 3.83649638 |
| 46 | exogenous drug catabolic process (GO:0042738) | 3.83050280 |
| 47 | cholesterol efflux (GO:0033344) | 3.78541142 |
| 48 | triglyceride homeostasis (GO:0070328) | 3.78193268 |
| 49 | acylglycerol homeostasis (GO:0055090) | 3.78193268 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 3.76128252 |
| 51 | low-density lipoprotein particle remodeling (GO:0034374) | 3.74466793 |
| 52 | indolalkylamine metabolic process (GO:0006586) | 3.71619360 |
| 53 | omega-hydroxylase P450 pathway (GO:0097267) | 3.66761424 |
| 54 | negative regulation of sterol transport (GO:0032372) | 3.64879436 |
| 55 | negative regulation of cholesterol transport (GO:0032375) | 3.64879436 |
| 56 | COPII vesicle coating (GO:0048208) | 3.62616167 |
| 57 | acute-phase response (GO:0006953) | 3.61616190 |
| 58 | ethanol oxidation (GO:0006069) | 3.61400736 |
| 59 | cellular zinc ion homeostasis (GO:0006882) | 3.60477388 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 3.60288069 |
| 61 | bile acid and bile salt transport (GO:0015721) | 3.57510456 |
| 62 | cellular glucuronidation (GO:0052695) | 3.57504701 |
| 63 | positive regulation of lipid catabolic process (GO:0050996) | 3.55768644 |
| 64 | amino-acid betaine metabolic process (GO:0006577) | 3.55105932 |
| 65 | cellular biogenic amine catabolic process (GO:0042402) | 3.53126544 |
| 66 | amine catabolic process (GO:0009310) | 3.53126544 |
| 67 | fibrinolysis (GO:0042730) | 3.51561935 |
| 68 | opsonization (GO:0008228) | 3.49220398 |
| 69 | lysine metabolic process (GO:0006553) | 3.46777137 |
| 70 | lysine catabolic process (GO:0006554) | 3.46777137 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 3.46068853 |
| 72 | phospholipid homeostasis (GO:0055091) | 3.41144632 |
| 73 | coenzyme catabolic process (GO:0009109) | 3.39141682 |
| 74 | cofactor catabolic process (GO:0051187) | 3.38591432 |
| 75 | arginine metabolic process (GO:0006525) | 3.38047215 |
| 76 | uronic acid metabolic process (GO:0006063) | 3.38000313 |
| 77 | glucuronate metabolic process (GO:0019585) | 3.38000313 |
| 78 | macroautophagy (GO:0016236) | 3.37603428 |
| 79 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.36784345 |
| 80 | negative regulation of humoral immune response (GO:0002921) | 3.33008235 |
| 81 | imidazole-containing compound metabolic process (GO:0052803) | 3.32811432 |
| 82 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.32312770 |
| 83 | ethanol metabolic process (GO:0006067) | 3.31942391 |
| 84 | plasma lipoprotein particle organization (GO:0071827) | 3.31164387 |
| 85 | positive regulation of hormone metabolic process (GO:0032352) | 3.29335008 |
| 86 | intestinal cholesterol absorption (GO:0030299) | 3.29059232 |
| 87 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.28976928 |
| 88 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.27563822 |
| 89 | glutamate metabolic process (GO:0006536) | 3.26923151 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 3.26427299 |
| 91 | benzene-containing compound metabolic process (GO:0042537) | 3.26199917 |
| 92 | protein activation cascade (GO:0072376) | 3.25269716 |
| 93 | cellular modified amino acid catabolic process (GO:0042219) | 3.24839402 |
| 94 | lipoprotein metabolic process (GO:0042157) | 3.24266451 |
| 95 | glycogen catabolic process (GO:0005980) | 3.23819977 |
| 96 | regulation of cholesterol homeostasis (GO:2000188) | 3.21902085 |
| 97 | complement activation (GO:0006956) | 3.21249440 |
| 98 | NAD biosynthetic process (GO:0009435) | 3.18091601 |
| 99 | biotin metabolic process (GO:0006768) | 3.15822173 |
| 100 | protein-lipid complex assembly (GO:0065005) | 3.13381375 |
| 101 | cellular ketone body metabolic process (GO:0046950) | 3.13361583 |
| 102 | protein-lipid complex subunit organization (GO:0071825) | 3.13146139 |
| 103 | desmosome organization (GO:0002934) | 3.13063730 |
| 104 | blood coagulation, intrinsic pathway (GO:0007597) | 3.11558954 |
| 105 | complement activation, classical pathway (GO:0006958) | 3.11307191 |
| 106 | cholesterol homeostasis (GO:0042632) | 3.11090974 |
| 107 | sterol homeostasis (GO:0055092) | 3.08016358 |
| 108 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.06633151 |
| 109 | phenylpropanoid metabolic process (GO:0009698) | 3.02879242 |
| 110 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.02513734 |
| 111 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.02513734 |
| 112 | positive regulation of hemostasis (GO:1900048) | 3.01264817 |
| 113 | positive regulation of blood coagulation (GO:0030194) | 3.01264817 |
| 114 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.99367473 |
| 115 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.99367473 |
| 116 | regulation of bile acid biosynthetic process (GO:0070857) | 2.98645730 |
| 117 | intestinal epithelial cell development (GO:0060576) | 2.98576742 |
| 118 | low-density lipoprotein particle clearance (GO:0034383) | 2.98109878 |
| 119 | drug catabolic process (GO:0042737) | 2.97690937 |
| 120 | glucan catabolic process (GO:0009251) | 2.93939336 |
| 121 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.93184078 |
| 122 | COPI coating of Golgi vesicle (GO:0048205) | 2.82804760 |
| 123 | Golgi transport vesicle coating (GO:0048200) | 2.82804760 |
| 124 | amino-acid betaine transport (GO:0015838) | 2.82413773 |
| 125 | carnitine transport (GO:0015879) | 2.82413773 |
| 126 | carnitine shuttle (GO:0006853) | 2.79975714 |
| 127 | cellular polysaccharide catabolic process (GO:0044247) | 2.74106065 |
| 128 | regulation of plasminogen activation (GO:0010755) | 2.72578785 |
| 129 | positive regulation of glycolytic process (GO:0045821) | 2.70670636 |
| 130 | positive regulation of gluconeogenesis (GO:0045722) | 2.70615366 |
| 131 | fatty acid homeostasis (GO:0055089) | 2.69230586 |
| 132 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.68107229 |
| 133 | quaternary ammonium group transport (GO:0015697) | 2.65552477 |
| 134 | skeletal muscle contraction (GO:0003009) | 2.64668559 |
| 135 | vitamin transmembrane transport (GO:0035461) | 2.64513845 |
| 136 | regulation of apoptotic cell clearance (GO:2000425) | 2.61257447 |
| 137 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.59845569 |
| 138 | plasma membrane repair (GO:0001778) | 2.59136663 |
| 139 | carnitine transmembrane transport (GO:1902603) | 2.59093053 |
| 140 | zinc ion transmembrane transport (GO:0071577) | 2.58859387 |
| 141 | zinc ion homeostasis (GO:0055069) | 2.58637118 |
| 142 | regulation of humoral immune response (GO:0002920) | 2.53085019 |
| 143 | heme transport (GO:0015886) | 2.49485840 |
| 144 | positive regulation of steroid metabolic process (GO:0045940) | 2.48651142 |
| 145 | exocrine pancreas development (GO:0031017) | 2.45687149 |
| 146 | skeletal muscle adaptation (GO:0043501) | 2.45504506 |
| 147 | peptide hormone processing (GO:0016486) | 2.42671358 |
| 148 | toxin transport (GO:1901998) | 2.41894339 |
| 149 | fatty acid transmembrane transport (GO:1902001) | 2.40725844 |
| 150 | polysaccharide catabolic process (GO:0000272) | 2.40054042 |
| 151 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.39820252 |
| 152 | drug metabolic process (GO:0017144) | 2.39665041 |
| 153 | glutamine family amino acid catabolic process (GO:0009065) | 2.39399009 |
| 154 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.39255277 |
| 155 | positive regulation of macroautophagy (GO:0016239) | 2.39079606 |
| 156 | regulation of hexokinase activity (GO:1903299) | 2.38828192 |
| 157 | regulation of glucokinase activity (GO:0033131) | 2.38828192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.22914707 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.68154698 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.64263321 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.60132552 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.38609963 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.60900496 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.04302429 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.90519293 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.28827740 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.26229317 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.18368477 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.01306883 |
| 13 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.76753769 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.74780842 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.65400754 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.59945095 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.27804261 |
| 18 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.22458196 |
| 19 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.21195045 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 2.16157350 |
| 21 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.10816774 |
| 22 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.95539117 |
| 23 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.93565440 |
| 24 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.91052826 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.89700999 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88229848 |
| 27 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.86488656 |
| 28 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.83710847 |
| 29 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.82323118 |
| 30 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.80972014 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.74731910 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.73898185 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68436017 |
| 34 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.59706075 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54929720 |
| 36 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.54684064 |
| 37 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50533747 |
| 38 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.49606032 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46836542 |
| 40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.45935707 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.45710810 |
| 42 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.37920186 |
| 43 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.31359562 |
| 44 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.31321646 |
| 45 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29079952 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.28458909 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.28458909 |
| 48 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.26554274 |
| 49 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26386280 |
| 50 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25503119 |
| 51 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.25366695 |
| 52 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.24231794 |
| 53 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.19909770 |
| 54 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17256425 |
| 55 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.14957301 |
| 56 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13153898 |
| 57 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10970955 |
| 58 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07957203 |
| 59 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07957203 |
| 60 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.07427332 |
| 61 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06060955 |
| 62 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04130057 |
| 63 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.03413470 |
| 64 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.01312839 |
| 65 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.00155937 |
| 66 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.99756612 |
| 67 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96474488 |
| 68 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.96052193 |
| 69 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92985815 |
| 70 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.91615088 |
| 71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89516173 |
| 72 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89054805 |
| 73 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.86487371 |
| 74 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.86286080 |
| 75 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85514177 |
| 76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.85035486 |
| 77 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.84968194 |
| 78 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84938509 |
| 79 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84279145 |
| 80 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.84202515 |
| 81 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84090261 |
| 82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.83475244 |
| 83 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.81707608 |
| 84 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.80966591 |
| 85 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80753957 |
| 86 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.80003935 |
| 87 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.79723936 |
| 88 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.78125581 |
| 89 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77523679 |
| 90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77285656 |
| 91 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76727995 |
| 92 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.76293708 |
| 93 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.76251777 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76118873 |
| 95 | STAT3_23295773_ChIP-Seq_U87_Human | 0.74797769 |
| 96 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.74607348 |
| 97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.74241557 |
| 98 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74219552 |
| 99 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.73996280 |
| 100 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.73412437 |
| 101 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.73328336 |
| 102 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.72820520 |
| 103 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.72731842 |
| 104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.72307459 |
| 105 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.72049612 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.71926043 |
| 107 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.71177206 |
| 108 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.70606015 |
| 109 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.70257462 |
| 110 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.69996097 |
| 111 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.69763209 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.69589868 |
| 113 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.69423862 |
| 114 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.69382428 |
| 115 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.68359617 |
| 116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.67686626 |
| 117 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.67552540 |
| 118 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.66144885 |
| 119 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.64827233 |
| 120 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63642467 |
| 121 | GATA1_19941826_ChIP-Seq_K562_Human | 0.63230773 |
| 122 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.62873452 |
| 123 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.62776929 |
| 124 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.62014300 |
| 125 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.61003085 |
| 126 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.60743727 |
| 127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.58109136 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.57877087 |
| 129 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.56800884 |
| 130 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.55694876 |
| 131 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.55489133 |
| 132 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.55467825 |
| 133 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.55205597 |
| 134 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.54662497 |
| 135 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.54455180 |
| 136 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.53856842 |
| 137 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.53105568 |
| 138 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.52935575 |
| 139 | GATA3_26560356_Chip-Seq_TH2_Human | 0.52783884 |
| 140 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.52701804 |
| 141 | AR_20517297_ChIP-Seq_VCAP_Human | 0.51644766 |
| 142 | CJUN_26792858_Chip-Seq_BT549_Human | 0.51067978 |
| 143 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.50586138 |
| 144 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.50458826 |
| 145 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49761591 |
| 146 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.48688155 |
| 147 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48606888 |
| 148 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.47490217 |
| 149 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.47396786 |
| 150 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.46806410 |
| 151 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.46623669 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.83026090 |
| 2 | MP0005360_urolithiasis | 6.00702187 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.18921748 |
| 4 | MP0005365_abnormal_bile_salt | 5.11867298 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 4.52832001 |
| 6 | MP0003195_calcinosis | 4.12179503 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.01361813 |
| 8 | MP0003252_abnormal_bile_duct | 3.52990591 |
| 9 | MP0009840_abnormal_foam_cell | 3.16742845 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 3.15886256 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.90929682 |
| 12 | MP0005083_abnormal_biliary_tract | 2.77049323 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.54892694 |
| 14 | MP0000013_abnormal_adipose_tissue | 2.47183620 |
| 15 | MP0005332_abnormal_amino_acid | 2.38928619 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.33303488 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.19511145 |
| 18 | MP0002837_dystrophic_cardiac_calcinosis | 2.13016099 |
| 19 | MP0001666_abnormal_nutrient_absorption | 2.13000271 |
| 20 | MP0003724_increased_susceptibility_to | 1.98945895 |
| 21 | MP0003122_maternal_imprinting | 1.98914740 |
| 22 | MP0000003_abnormal_adipose_tissue | 1.98717795 |
| 23 | MP0000609_abnormal_liver_physiology | 1.96727519 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.89198197 |
| 25 | MP0003436_decreased_susceptibility_to | 1.88922073 |
| 26 | MP0002118_abnormal_lipid_homeostasis | 1.86738336 |
| 27 | MP0003123_paternal_imprinting | 1.82619988 |
| 28 | MP0004264_abnormal_extraembryonic_tissu | 1.79618390 |
| 29 | MP0004233_abnormal_muscle_weight | 1.78089227 |
| 30 | MP0003941_abnormal_skin_development | 1.75664610 |
| 31 | MP0005319_abnormal_enzyme/_coenzyme | 1.73140464 |
| 32 | MP0009764_decreased_sensitivity_to | 1.70640693 |
| 33 | MP0010678_abnormal_skin_adnexa | 1.65369100 |
| 34 | MP0003868_abnormal_feces_composition | 1.63914617 |
| 35 | MP0001661_extended_life_span | 1.59695780 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.58717754 |
| 37 | MP0000383_abnormal_hair_follicle | 1.56446458 |
| 38 | MP0006082_CNS_inflammation | 1.53973204 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.51887351 |
| 40 | MP0009785_altered_susceptibility_to | 1.46429042 |
| 41 | MP0003186_abnormal_redox_activity | 1.45942132 |
| 42 | MP0002269_muscular_atrophy | 1.45318418 |
| 43 | MP0001764_abnormal_homeostasis | 1.45024434 |
| 44 | MP0008469_abnormal_protein_level | 1.43444136 |
| 45 | MP0000751_myopathy | 1.40330686 |
| 46 | MP0003646_muscle_fatigue | 1.39794681 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.38681650 |
| 48 | MP0004036_abnormal_muscle_relaxation | 1.35957756 |
| 49 | MP0001835_abnormal_antigen_presentation | 1.34218910 |
| 50 | MP0002419_abnormal_innate_immunity | 1.33058755 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.32526242 |
| 52 | MP0000604_amyloidosis | 1.31707209 |
| 53 | MP0003303_peritoneal_inflammation | 1.28869462 |
| 54 | MP0002108_abnormal_muscle_morphology | 1.28186303 |
| 55 | MP0004270_analgesia | 1.25282045 |
| 56 | MP0005646_abnormal_pituitary_gland | 1.23351827 |
| 57 | MP0003075_altered_response_to | 1.22382249 |
| 58 | MP0009763_increased_sensitivity_to | 1.22212841 |
| 59 | MP0004087_abnormal_muscle_fiber | 1.20770877 |
| 60 | MP0002254_reproductive_system_inflammat | 1.18940863 |
| 61 | MP0003879_abnormal_hair_cell | 1.18876997 |
| 62 | MP0003705_abnormal_hypodermis_morpholog | 1.17045087 |
| 63 | MP0000462_abnormal_digestive_system | 1.15660573 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.13654141 |
| 65 | MP0003656_abnormal_erythrocyte_physiolo | 1.13481929 |
| 66 | MP0005369_muscle_phenotype | 1.12727009 |
| 67 | MP0005375_adipose_tissue_phenotype | 1.12300330 |
| 68 | MP0002078_abnormal_glucose_homeostasis | 1.12134321 |
| 69 | MP0005025_abnormal_response_to | 1.12020497 |
| 70 | MP0002106_abnormal_muscle_physiology | 1.11956615 |
| 71 | MP0005330_cardiomyopathy | 1.10779842 |
| 72 | MP0005451_abnormal_body_composition | 1.10493840 |
| 73 | MP0002148_abnormal_hypersensitivity_rea | 1.08304331 |
| 74 | MP0003690_abnormal_glial_cell | 1.07974369 |
| 75 | MP0000598_abnormal_liver_morphology | 1.07656452 |
| 76 | MP0000749_muscle_degeneration | 1.05685489 |
| 77 | MP0009697_abnormal_copulation | 1.05091317 |
| 78 | MP0000747_muscle_weakness | 1.04824101 |
| 79 | MP0002693_abnormal_pancreas_physiology | 1.03401176 |
| 80 | MP0001533_abnormal_skeleton_physiology | 1.02273517 |
| 81 | MP0005645_abnormal_hypothalamus_physiol | 1.02145336 |
| 82 | MP0003283_abnormal_digestive_organ | 1.01842438 |
| 83 | MP0005220_abnormal_exocrine_pancreas | 0.99000825 |
| 84 | MP0004782_abnormal_surfactant_physiolog | 0.98120124 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.97702118 |
| 86 | MP0005000_abnormal_immune_tolerance | 0.97587864 |
| 87 | MP0010352_gastrointestinal_tract_polyps | 0.97547722 |
| 88 | MP0001845_abnormal_inflammatory_respons | 0.96571478 |
| 89 | MP0005535_abnormal_body_temperature | 0.96234290 |
| 90 | MP0005409_darkened_coat_color | 0.95677532 |
| 91 | MP0005408_hypopigmentation | 0.95015440 |
| 92 | MP0004947_skin_inflammation | 0.94480570 |
| 93 | MP0009642_abnormal_blood_homeostasis | 0.93961765 |
| 94 | MP0005636_abnormal_mineral_homeostasis | 0.93047866 |
| 95 | MP0004130_abnormal_muscle_cell | 0.92098187 |
| 96 | MP0000639_abnormal_adrenal_gland | 0.88501478 |
| 97 | MP0005166_decreased_susceptibility_to | 0.88340722 |
| 98 | MP0001790_abnormal_immune_system | 0.87595248 |
| 99 | MP0005387_immune_system_phenotype | 0.87595248 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.87481707 |
| 101 | MP0001756_abnormal_urination | 0.86079355 |
| 102 | MP0002896_abnormal_bone_mineralization | 0.84502735 |
| 103 | MP0002163_abnormal_gland_morphology | 0.84497590 |
| 104 | MP0003183_abnormal_peptide_metabolism | 0.84486800 |
| 105 | MP0001944_abnormal_pancreas_morphology | 0.83307729 |
| 106 | MP0002160_abnormal_reproductive_system | 0.81807512 |
| 107 | MP0005379_endocrine/exocrine_gland_phen | 0.81294075 |
| 108 | MP0009672_abnormal_birth_weight | 0.80886468 |
| 109 | MP0004272_abnormal_basement_membrane | 0.80402689 |
| 110 | MP0003011_delayed_dark_adaptation | 0.80292119 |
| 111 | MP0004215_abnormal_myocardial_fiber | 0.79344454 |
| 112 | MP0002796_impaired_skin_barrier | 0.78439673 |
| 113 | MP0000759_abnormal_skeletal_muscle | 0.78198638 |
| 114 | MP0002127_abnormal_cardiovascular_syste | 0.78088898 |
| 115 | MP0005647_abnormal_sex_gland | 0.77385300 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.75991386 |
| 117 | MP0005334_abnormal_fat_pad | 0.75820078 |
| 118 | MP0000685_abnormal_immune_system | 0.75166951 |
| 119 | MP0004084_abnormal_cardiac_muscle | 0.74915025 |
| 120 | MP0002168_other_aberrant_phenotype | 0.73260986 |
| 121 | MP0005670_abnormal_white_adipose | 0.73218081 |
| 122 | MP0005076_abnormal_cell_differentiation | 0.73213733 |
| 123 | MP0001853_heart_inflammation | 0.73032230 |
| 124 | MP0005376_homeostasis/metabolism_phenot | 0.71734108 |
| 125 | MP0005084_abnormal_gallbladder_morpholo | 0.71017307 |
| 126 | MP0002971_abnormal_brown_adipose | 0.70728084 |
| 127 | MP0003890_abnormal_embryonic-extraembry | 0.70056523 |
| 128 | MP0009703_decreased_birth_body | 0.69462712 |
| 129 | MP0005164_abnormal_response_to | 0.69379497 |
| 130 | MP0002938_white_spotting | 0.68975039 |
| 131 | MP0009765_abnormal_xenobiotic_induced | 0.67893251 |
| 132 | MP0010368_abnormal_lymphatic_system | 0.67469407 |
| 133 | MP0003300_gastrointestinal_ulcer | 0.66965250 |
| 134 | MP0005448_abnormal_energy_balance | 0.66893156 |
| 135 | MP0002928_abnormal_bile_duct | 0.66525638 |
| 136 | MP0000566_synostosis | 0.66172788 |
| 137 | MP0005167_abnormal_blood-brain_barrier | 0.65839073 |
| 138 | MP0003566_abnormal_cell_adhesion | 0.65819062 |
| 139 | MP0002723_abnormal_immune_serum | 0.65554141 |
| 140 | MP0002136_abnormal_kidney_physiology | 0.64376753 |
| 141 | MP0010630_abnormal_cardiac_muscle | 0.64272525 |
| 142 | MP0002009_preneoplasia | 0.63875979 |
| 143 | MP0004043_abnormal_pH_regulation | 0.62157329 |
| 144 | MP0000427_abnormal_hair_cycle | 0.61984957 |
| 145 | MP0005620_abnormal_muscle_contractility | 0.61441570 |
| 146 | MP0004510_myositis | 0.60395470 |
| 147 | MP0002452_abnormal_antigen_presenting | 0.58708637 |
| 148 | MP0002090_abnormal_vision | 0.58481939 |
| 149 | MP0002998_abnormal_bone_remodeling | 0.57252625 |
| 150 | MP0002877_abnormal_melanocyte_morpholog | 0.56424727 |
| 151 | MP0001800_abnormal_humoral_immune | 0.55696385 |
| 152 | MP0002876_abnormal_thyroid_physiology | 0.55160529 |
| 153 | MP0010386_abnormal_urinary_bladder | 0.53505223 |
| 154 | MP0003953_abnormal_hormone_level | 0.53001184 |
| 155 | MP0005395_other_phenotype | 0.52452181 |
| 156 | MP0005248_abnormal_Harderian_gland | 0.51404994 |
| 157 | MP0002909_abnormal_adrenal_gland | 0.49437522 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.59597213 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.09045681 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 5.98422163 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.98066523 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.90055546 |
| 6 | Xanthomatosis (HP:0000991) | 5.52819666 |
| 7 | Complement deficiency (HP:0004431) | 4.99826210 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.89780726 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 4.89778561 |
| 10 | Joint hemorrhage (HP:0005261) | 4.86348347 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.61036724 |
| 12 | Abnormality of the common coagulation pathway (HP:0010990) | 4.54322919 |
| 13 | Hypoglycemic coma (HP:0001325) | 4.47315176 |
| 14 | Epidermoid cyst (HP:0200040) | 4.28379171 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 4.00194136 |
| 16 | Abnormality of complement system (HP:0005339) | 3.87080266 |
| 17 | Hypolipoproteinemia (HP:0010981) | 3.84246530 |
| 18 | Ketosis (HP:0001946) | 3.77134044 |
| 19 | Muscle fiber inclusion bodies (HP:0100299) | 3.72433656 |
| 20 | Hypoglycemic seizures (HP:0002173) | 3.71817259 |
| 21 | Conjugated hyperbilirubinemia (HP:0002908) | 3.69132401 |
| 22 | Exercise-induced myalgia (HP:0003738) | 3.68219534 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.67782280 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.67373860 |
| 25 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.58221674 |
| 26 | Fat malabsorption (HP:0002630) | 3.56511244 |
| 27 | Nemaline bodies (HP:0003798) | 3.54337485 |
| 28 | Hypoalphalipoproteinemia (HP:0003233) | 3.54187230 |
| 29 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.50848007 |
| 30 | Hyperammonemia (HP:0001987) | 3.49479419 |
| 31 | Myocardial infarction (HP:0001658) | 3.49358144 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.47041356 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.38145051 |
| 34 | Abnormality of methionine metabolism (HP:0010901) | 3.34499751 |
| 35 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.30695342 |
| 36 | Ketoacidosis (HP:0001993) | 3.24729352 |
| 37 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.21514883 |
| 38 | Glomerulonephritis (HP:0000099) | 3.13525819 |
| 39 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.12115049 |
| 40 | Hyperphosphatemia (HP:0002905) | 3.04789944 |
| 41 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.03716212 |
| 42 | Asymmetry of the thorax (HP:0001555) | 3.00179829 |
| 43 | Skin nodule (HP:0200036) | 2.99282543 |
| 44 | Hyperglycinemia (HP:0002154) | 2.98927404 |
| 45 | Exercise-induced muscle cramps (HP:0003710) | 2.97456266 |
| 46 | Mitral stenosis (HP:0001718) | 2.89749026 |
| 47 | J-shaped sella turcica (HP:0002680) | 2.85244435 |
| 48 | Eczematoid dermatitis (HP:0000976) | 2.84252144 |
| 49 | Right ventricular cardiomyopathy (HP:0011663) | 2.83589453 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.81946824 |
| 51 | Symptomatic seizures (HP:0011145) | 2.81648906 |
| 52 | Hyperglycemia (HP:0003074) | 2.78579829 |
| 53 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.76402626 |
| 54 | Hyperbilirubinemia (HP:0002904) | 2.75454021 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.72035663 |
| 56 | Calf muscle hypertrophy (HP:0008981) | 2.70245437 |
| 57 | Hyperglycinuria (HP:0003108) | 2.69884015 |
| 58 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.67446340 |
| 59 | Hepatocellular carcinoma (HP:0001402) | 2.64504828 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.62162795 |
| 61 | Type 1 muscle fiber predominance (HP:0003803) | 2.59465768 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.59135058 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.59135058 |
| 64 | Gingival bleeding (HP:0000225) | 2.58103610 |
| 65 | Steatorrhea (HP:0002570) | 2.57967013 |
| 66 | Late onset (HP:0003584) | 2.53278219 |
| 67 | Recurrent bacterial skin infections (HP:0005406) | 2.52115909 |
| 68 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.50108504 |
| 69 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.49403192 |
| 70 | Esophageal varix (HP:0002040) | 2.43463401 |
| 71 | Testicular neoplasm (HP:0010788) | 2.41276338 |
| 72 | Spontaneous abortion (HP:0005268) | 2.40343963 |
| 73 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.38779817 |
| 74 | Menorrhagia (HP:0000132) | 2.34611480 |
| 75 | Irritability (HP:0000737) | 2.33963195 |
| 76 | Hyporeflexia of lower limbs (HP:0002600) | 2.31870939 |
| 77 | Congenital malformation of the right heart (HP:0011723) | 2.31301192 |
| 78 | Double outlet right ventricle (HP:0001719) | 2.31301192 |
| 79 | Bundle branch block (HP:0011710) | 2.27456494 |
| 80 | Myoglobinuria (HP:0002913) | 2.25487525 |
| 81 | Papillary thyroid carcinoma (HP:0002895) | 2.23229213 |
| 82 | Amyloidosis (HP:0011034) | 2.20193667 |
| 83 | Hemorrhage of the eye (HP:0011885) | 2.20003281 |
| 84 | EMG: myopathic abnormalities (HP:0003458) | 2.19777398 |
| 85 | Generalized aminoaciduria (HP:0002909) | 2.17976108 |
| 86 | Nephritis (HP:0000123) | 2.17673478 |
| 87 | Vascular calcification (HP:0004934) | 2.16438549 |
| 88 | Abnormality of the calf musculature (HP:0001430) | 2.14538306 |
| 89 | Autoimmune thrombocytopenia (HP:0001973) | 2.11375614 |
| 90 | Vacuolated lymphocytes (HP:0001922) | 2.11113930 |
| 91 | Pancreatitis (HP:0001733) | 2.10920547 |
| 92 | Septate vagina (HP:0001153) | 2.10581392 |
| 93 | Pheochromocytoma (HP:0002666) | 2.08898399 |
| 94 | Retinal atrophy (HP:0001105) | 2.08767371 |
| 95 | Abnormal gallbladder morphology (HP:0012437) | 2.06894318 |
| 96 | Recurrent abscess formation (HP:0002722) | 2.06297503 |
| 97 | Osteomalacia (HP:0002749) | 2.05878984 |
| 98 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.04967268 |
| 99 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.04967268 |
| 100 | Abnormality of vitamin metabolism (HP:0100508) | 2.03820537 |
| 101 | Abnormality of serum amino acid levels (HP:0003112) | 2.02183246 |
| 102 | Metabolic acidosis (HP:0001942) | 2.01998982 |
| 103 | Axonal loss (HP:0003447) | 2.01158786 |
| 104 | Abnormality of proline metabolism (HP:0010907) | 2.00780777 |
| 105 | Hydroxyprolinuria (HP:0003080) | 2.00780777 |
| 106 | Joint swelling (HP:0001386) | 2.00646094 |
| 107 | Mucopolysacchariduria (HP:0008155) | 2.00488678 |
| 108 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00488678 |
| 109 | Acanthocytosis (HP:0001927) | 1.99364052 |
| 110 | Delayed CNS myelination (HP:0002188) | 1.98720774 |
| 111 | Hyperkalemia (HP:0002153) | 1.98154101 |
| 112 | Sensorimotor neuropathy (HP:0007141) | 1.97697056 |
| 113 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96782236 |
| 114 | Cardiovascular calcification (HP:0011915) | 1.95173005 |
| 115 | Thrombophlebitis (HP:0004418) | 1.94318689 |
| 116 | Hypochromic microcytic anemia (HP:0004840) | 1.93454046 |
| 117 | Tetraparesis (HP:0002273) | 1.93109306 |
| 118 | Spastic diplegia (HP:0001264) | 1.92873397 |
| 119 | Elevated alkaline phosphatase (HP:0003155) | 1.92764347 |
| 120 | Abnormal pancreas size (HP:0012094) | 1.91556593 |
| 121 | Gout (HP:0001997) | 1.90265359 |
| 122 | Round ear (HP:0100830) | 1.88891425 |
| 123 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.88146301 |
| 124 | Rhabdomyolysis (HP:0003201) | 1.88087050 |
| 125 | Nausea (HP:0002018) | 1.87476175 |
| 126 | Dysostosis multiplex (HP:0000943) | 1.87260703 |
| 127 | Abnormality of iron homeostasis (HP:0011031) | 1.87211462 |
| 128 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87203241 |
| 129 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.86610605 |
| 130 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.86610605 |
| 131 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.86610605 |
| 132 | Ulnar deviation of the wrist (HP:0003049) | 1.85933906 |
| 133 | Stroke (HP:0001297) | 1.84593934 |
| 134 | Menstrual irregularities (HP:0000858) | 1.84141765 |
| 135 | Thyroid carcinoma (HP:0002890) | 1.82703125 |
| 136 | Abnormality of macrophages (HP:0004311) | 1.82680024 |
| 137 | Macroorchidism (HP:0000053) | 1.80036145 |
| 138 | Rimmed vacuoles (HP:0003805) | 1.80028535 |
| 139 | Enlarged penis (HP:0000040) | 1.78603066 |
| 140 | Large for gestational age (HP:0001520) | 1.76060980 |
| 141 | Fetal akinesia sequence (HP:0001989) | 1.72601270 |
| 142 | Neuroendocrine neoplasm (HP:0100634) | 1.72472534 |
| 143 | Distal arthrogryposis (HP:0005684) | 1.70348056 |
| 144 | Hyperphosphaturia (HP:0003109) | 1.69869170 |
| 145 | Sudden death (HP:0001699) | 1.69730329 |
| 146 | Fair hair (HP:0002286) | 1.69402307 |
| 147 | Rickets (HP:0002748) | 1.68766915 |
| 148 | Hypothermia (HP:0002045) | 1.67844782 |
| 149 | Increased circulating renin level (HP:0000848) | 1.67096608 |
| 150 | Myopathic facies (HP:0002058) | 1.66889778 |
| 151 | Popliteal pterygium (HP:0009756) | 1.66336639 |
| 152 | Flat acetabular roof (HP:0003180) | 1.62222462 |
| 153 | Back pain (HP:0003418) | 1.61385089 |
| 154 | Microglossia (HP:0000171) | 1.60826054 |
| 155 | Goiter (HP:0000853) | 1.60105128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.19277534 |
| 2 | ERN1 | 4.02608656 |
| 3 | INSRR | 3.72461248 |
| 4 | TAOK3 | 3.59359400 |
| 5 | EEF2K | 3.25994855 |
| 6 | PHKG2 | 3.20592595 |
| 7 | PHKG1 | 3.20592595 |
| 8 | PBK | 3.08315658 |
| 9 | MAP3K14 | 2.99655576 |
| 10 | SIK1 | 2.96929200 |
| 11 | FGFR4 | 2.93857585 |
| 12 | BCKDK | 2.77838227 |
| 13 | SCYL2 | 2.73961301 |
| 14 | MAPK15 | 2.73288486 |
| 15 | MAPKAPK3 | 2.70646525 |
| 16 | MST1R | 2.62606690 |
| 17 | PIK3CA | 2.55715821 |
| 18 | IRAK3 | 2.55580528 |
| 19 | RIPK4 | 2.51410641 |
| 20 | TYK2 | 2.47457208 |
| 21 | TRPM7 | 2.46744161 |
| 22 | PIK3CG | 2.41879310 |
| 23 | TBK1 | 2.27886175 |
| 24 | RPS6KB2 | 2.21153395 |
| 25 | ERBB4 | 2.17290301 |
| 26 | EPHA2 | 2.09380437 |
| 27 | AKT3 | 2.07248303 |
| 28 | TTN | 1.99836650 |
| 29 | JAK1 | 1.98430823 |
| 30 | FGFR2 | 1.93405637 |
| 31 | BLK | 1.78618524 |
| 32 | FRK | 1.77073005 |
| 33 | NEK6 | 1.65376009 |
| 34 | MST4 | 1.65215302 |
| 35 | FER | 1.60764161 |
| 36 | STK38L | 1.59086312 |
| 37 | IKBKE | 1.55609450 |
| 38 | NEK9 | 1.53727470 |
| 39 | JAK3 | 1.51263021 |
| 40 | ABL2 | 1.50727553 |
| 41 | IRAK4 | 1.50650402 |
| 42 | EPHA3 | 1.48304991 |
| 43 | JAK2 | 1.44561703 |
| 44 | CSK | 1.43779688 |
| 45 | STK39 | 1.42060299 |
| 46 | WNK4 | 1.39830611 |
| 47 | MUSK | 1.39486226 |
| 48 | WNK3 | 1.39346733 |
| 49 | ICK | 1.36335757 |
| 50 | LATS2 | 1.32672001 |
| 51 | FLT3 | 1.30627291 |
| 52 | EIF2AK1 | 1.30430820 |
| 53 | LATS1 | 1.26683334 |
| 54 | TRIB3 | 1.23001867 |
| 55 | MAP3K13 | 1.22675726 |
| 56 | PTK6 | 1.15461499 |
| 57 | IRAK1 | 1.15304064 |
| 58 | NME1 | 1.11565429 |
| 59 | IKBKB | 1.08713503 |
| 60 | MET | 1.07901243 |
| 61 | EIF2AK3 | 1.07346167 |
| 62 | MAP2K6 | 1.07083851 |
| 63 | PDK2 | 1.01930368 |
| 64 | RPS6KB1 | 1.01899801 |
| 65 | NTRK3 | 1.01360734 |
| 66 | RIPK1 | 1.00706465 |
| 67 | BMX | 0.99387171 |
| 68 | MAP3K1 | 0.98696928 |
| 69 | FGFR3 | 0.95125415 |
| 70 | MAP3K12 | 0.95023674 |
| 71 | MAPK11 | 0.94651844 |
| 72 | CAMK1G | 0.94406785 |
| 73 | CHUK | 0.92200101 |
| 74 | IRAK2 | 0.89935456 |
| 75 | MAP3K2 | 0.88802439 |
| 76 | DAPK2 | 0.86877689 |
| 77 | MTOR | 0.86446159 |
| 78 | EPHB1 | 0.86307694 |
| 79 | AKT2 | 0.84810638 |
| 80 | CAMK2D | 0.83886485 |
| 81 | ERBB3 | 0.83051381 |
| 82 | BRD4 | 0.82777827 |
| 83 | MAP2K4 | 0.80102773 |
| 84 | STK38 | 0.79119615 |
| 85 | MAP2K2 | 0.77952642 |
| 86 | PNCK | 0.67609595 |
| 87 | PKN2 | 0.67103051 |
| 88 | CAMK2G | 0.66765759 |
| 89 | CDK12 | 0.66210456 |
| 90 | FGFR1 | 0.64226166 |
| 91 | ZAP70 | 0.62806286 |
| 92 | MAP3K5 | 0.62653433 |
| 93 | PRKCH | 0.62135089 |
| 94 | KIT | 0.61637398 |
| 95 | BMPR2 | 0.61439101 |
| 96 | SGK2 | 0.61096773 |
| 97 | MAP3K9 | 0.60669806 |
| 98 | LYN | 0.60242347 |
| 99 | TXK | 0.57811197 |
| 100 | PDGFRA | 0.57153937 |
| 101 | DYRK1B | 0.56148382 |
| 102 | IGF1R | 0.55431612 |
| 103 | MAP3K10 | 0.55337604 |
| 104 | CAMK1D | 0.55119342 |
| 105 | YES1 | 0.55115691 |
| 106 | MAPK12 | 0.54539894 |
| 107 | ERBB2 | 0.54037827 |
| 108 | PRKACG | 0.53528826 |
| 109 | MAP4K1 | 0.52377692 |
| 110 | PRKAA2 | 0.52084297 |
| 111 | PRKCZ | 0.51880332 |
| 112 | EGFR | 0.51765866 |
| 113 | PDPK1 | 0.51647560 |
| 114 | CSNK1E | 0.50389983 |
| 115 | ABL1 | 0.49120066 |
| 116 | PTK2 | 0.48993302 |
| 117 | MAPKAPK5 | 0.48850712 |
| 118 | GSK3A | 0.47633243 |
| 119 | MARK3 | 0.45953256 |
| 120 | PASK | 0.44916287 |
| 121 | SGK223 | 0.44603110 |
| 122 | SGK494 | 0.44603110 |
| 123 | PRKD3 | 0.44419014 |
| 124 | STK24 | 0.44186309 |
| 125 | PRKCQ | 0.43495988 |
| 126 | SGK3 | 0.42426854 |
| 127 | PRKCD | 0.41803861 |
| 128 | STK3 | 0.41624752 |
| 129 | HIPK2 | 0.41546372 |
| 130 | PRKCI | 0.40393132 |
| 131 | HCK | 0.39627659 |
| 132 | OXSR1 | 0.36971136 |
| 133 | CSNK1D | 0.36236986 |
| 134 | SYK | 0.35892090 |
| 135 | KSR2 | 0.34970534 |
| 136 | NUAK1 | 0.34652008 |
| 137 | PRKAA1 | 0.34443267 |
| 138 | NTRK1 | 0.34179864 |
| 139 | MAP3K3 | 0.33507988 |
| 140 | RET | 0.32955186 |
| 141 | CDK6 | 0.32269772 |
| 142 | SMG1 | 0.31041742 |
| 143 | PRKACB | 0.30735644 |
| 144 | NLK | 0.30389547 |
| 145 | GRK1 | 0.29823495 |
| 146 | MATK | 0.29738270 |
| 147 | EIF2AK2 | 0.29454404 |
| 148 | RPS6KA4 | 0.28951482 |
| 149 | KDR | 0.28940340 |
| 150 | LCK | 0.28698985 |
| 151 | MAPK4 | 0.28656062 |
| 152 | PDK1 | 0.28226561 |
| 153 | SGK1 | 0.27138285 |
| 154 | LMTK2 | 0.26461447 |
| 155 | MAP3K4 | 0.26350460 |
| 156 | MAP2K1 | 0.25689781 |
| 157 | CSF1R | 0.25372312 |
| 158 | PDGFRB | 0.24510037 |
| 159 | BTK | 0.24451488 |
| 160 | MAP3K7 | 0.23562077 |
| 161 | PAK3 | 0.23535978 |
| 162 | PRKCE | 0.22130873 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.36291803 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.66839022 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.21782030 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.07928291 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07864830 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.04421421 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.81829844 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56121743 |
| 9 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.29328131 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.26877312 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.18407481 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.14274276 |
| 13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.99641705 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.97249469 |
| 15 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.93924793 |
| 16 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.86446233 |
| 17 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.83968333 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.81302826 |
| 19 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.80378996 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.73802150 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.72163602 |
| 22 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.71178902 |
| 23 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.65551583 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.62234307 |
| 25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.59499459 |
| 26 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.55451465 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51089005 |
| 28 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50410693 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49718151 |
| 30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.47463444 |
| 31 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.45188477 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.41877559 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.41666496 |
| 34 | ABC transporters_Homo sapiens_hsa02010 | 1.40864400 |
| 35 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.35506215 |
| 36 | Circadian rhythm_Homo sapiens_hsa04710 | 1.34425514 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33606477 |
| 38 | Bile secretion_Homo sapiens_hsa04976 | 1.33047144 |
| 39 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27785095 |
| 40 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.27121086 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.23728572 |
| 42 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23606113 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22565036 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.21396893 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.00770761 |
| 46 | Prion diseases_Homo sapiens_hsa05020 | 0.98442043 |
| 47 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98250891 |
| 48 | Insulin secretion_Homo sapiens_hsa04911 | 0.95566588 |
| 49 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90853819 |
| 50 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.89108372 |
| 51 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.87696265 |
| 52 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86996346 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86802443 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.86716566 |
| 55 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84925927 |
| 56 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84446527 |
| 57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.82336558 |
| 58 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.79826969 |
| 59 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79808826 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78326590 |
| 61 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.77003126 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76365579 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.75927916 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74807614 |
| 65 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.74527726 |
| 66 | Tight junction_Homo sapiens_hsa04530 | 0.70100874 |
| 67 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.69664195 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68721990 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.68326079 |
| 70 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68022377 |
| 71 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.67611218 |
| 72 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.66764156 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.64485386 |
| 74 | Lysine degradation_Homo sapiens_hsa00310 | 0.63163901 |
| 75 | Leishmaniasis_Homo sapiens_hsa05140 | 0.62968848 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.62911275 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.62511280 |
| 78 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62504326 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61147330 |
| 80 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61117675 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.60972723 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.59627030 |
| 83 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.59513557 |
| 84 | Malaria_Homo sapiens_hsa05144 | 0.55905476 |
| 85 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.52975148 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.52827732 |
| 87 | Insulin resistance_Homo sapiens_hsa04931 | 0.52065764 |
| 88 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51774193 |
| 89 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.51309662 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50384111 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.50023062 |
| 92 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48263687 |
| 93 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.47884096 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43744025 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43576690 |
| 96 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.43540616 |
| 97 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42421107 |
| 98 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.41801944 |
| 99 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.39558273 |
| 100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.38571799 |
| 101 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38379832 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.38051849 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.36401298 |
| 104 | Allograft rejection_Homo sapiens_hsa05330 | 0.35283432 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.35275361 |
| 106 | Tuberculosis_Homo sapiens_hsa05152 | 0.34385558 |
| 107 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33938554 |
| 108 | Renin secretion_Homo sapiens_hsa04924 | 0.33471244 |
| 109 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.33263091 |
| 110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32987221 |
| 111 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.32692439 |
| 112 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.31073695 |
| 113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30574797 |
| 114 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29287963 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29062019 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.27531306 |
| 117 | Phagosome_Homo sapiens_hsa04145 | 0.26295490 |
| 118 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.24158382 |
| 119 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23613968 |
| 120 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.23371717 |
| 121 | Influenza A_Homo sapiens_hsa05164 | 0.22286995 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.21869522 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.20666594 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.20164459 |
| 125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.19798683 |
| 126 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19770059 |
| 127 | Asthma_Homo sapiens_hsa05310 | 0.16711274 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.15335700 |
| 129 | Hepatitis C_Homo sapiens_hsa05160 | 0.14978532 |
| 130 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.14459841 |

